Plain-English translation of NCT07219173 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Asthma research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called to see if it can help adults whose asthma remains difficult to control even while taking regular asthma controller medicines. The study will compare at two different doses against placebo (a dummy injection with no active medicine) to measure how safe and effective this treatment is. About 531 people will participate over roughly 65 weeks.
Many people with moderate to severe asthma still struggle to keep their symptoms under control despite taking standard asthma medications. Researchers are testing this medication to see if it offers a better option for patients whose asthma isn't adequately controlled with current treatments.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would receive either the new medication or a placebo injection under the skin, along with your regular asthma medicines. You would visit the study clinic multiple times over about 65 weeks for check-ups, breathing tests, and follow-up visits. The study team will monitor how well your asthma is controlled and watch for any side effects throughout the year of treatment.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
United States